Details for New Drug Application (NDA): 017924
✉ Email this page to a colleague
The generic ingredient in TAGAMET is cimetidine. There are twenty-five drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the cimetidine profile page.
Summary for 017924
Tradename: | TAGAMET |
Applicant: | Glaxosmithkline |
Ingredient: | cimetidine hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | EQ 300MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 017924
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | TAGAMET | cimetidine hydrochloride | SOLUTION;ORAL | 017924-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | TAGAMET | cimetidine hydrochloride | SOLUTION;ORAL | 017924-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription